411: FOUR-FACTOR PCC VERSUS ANDEXANET ALFA FOR ORAL FACTOR XA INHIBITOR-ASSOCIATED MAJOR BLEEDS. (January 2022) - Kafka, Wesley; Nowling, Anthony; Patel, Apexa